Reviewed,
UniProtKB/Swiss-Prot P05771 (KPCB_HUMAN)
Last modified
July 7, 2009.
Version 131.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Protein kinase C beta type Short name=PKC-beta Short name=PKC-B EC=2.7.11.13 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 671 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | This is a calcium-activated, phospholipid-dependent, serine- and threonine-specific enzyme. PKC is activated by diacylglycerol which in turn phosphorylates a range of cellular proteins. PKC also serves as the receptor for phorbol esters, a class of tumor promoters. May be considered as a novel component of the NF-kappa-B signaling axis responsible for the survival and activation of B-cells after BCR cross-linking By similarity. |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Cofactor | Binds 3 calcium ions per subunit. The ions are bound to the C2 domain By similarity. |
| Subunit structure | Interacts with PDK1 By similarity. Interacts in vitro with PRKCBP1. |
| Subcellular location | Cytoplasm By similarity. Membrane; Peripheral membrane protein By similarity. |
| Post-translational modification | Phosphorylation on Thr-500 of isoform beta-I, within the activation loop, renders it competent to autophosphorylate. Subsequent autophosphorylation of Thr-642 maintains catalytic competence, and autophosphorylation on Ser-661 appears to release the kinase into the cytosol. Similarly, isoform beta-II is autophosphorylated on 'Thr-640' and 'Ser-659', subsequent to phosphorylation on Thr-500. Autophosphorylated on other sites i.e. in the N-terminal and hinge regions have no effect on PKC activity By similarity. |
| Sequence similarities | Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily. Contains 1 AGC-kinase C-terminal domain. Contains 1 C2 domain. Contains 2 phorbol-ester/DAG-type zinc fingers. Contains 1 protein kinase domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| PRL1 | Q42384 | 1 | EBI-706216,EBI-1382964 | From a different organism. |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform Beta-I (identifier: P05771-1) Also known as: PRKCB1; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Beta-II (identifier: P05771-2) Also known as: PRKCB2; The sequence of this isoform differs from the canonical sequence as follows: 622-671: RDKRDTSNFD...YTNPEFVINV → CGRNAENFDR...SEFLKPEVKS |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 2 – 671 | 670 | Protein kinase C beta type | PRO_0000055684 | |||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 173 – 260 | 88 | C2 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 342 – 600 | 259 | Protein kinase | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 601 – 671 | 71 | AGC-kinase C-terminal | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Zinc finger | 36 – 86 | 51 | Phorbol-ester/DAG-type 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Zinc finger | 101 – 151 | 51 | Phorbol-ester/DAG-type 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 348 – 356 | 9 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 466 | 1 | Proton acceptor By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 186 | 1 | Calcium 1; via carbonyl oxygen By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 187 | 1 | Calcium 1 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 187 | 1 | Calcium 2 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 193 | 1 | Calcium 2 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 246 | 1 | Calcium 1 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 246 | 1 | Calcium 2 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 247 | 1 | Calcium 2; via carbonyl oxygen By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 248 | 1 | Calcium 1 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 248 | 1 | Calcium 2 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 248 | 1 | Calcium 3 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 251 | 1 | Calcium 3 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 252 | 1 | Calcium 3; via carbonyl oxygen By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 254 | 1 | Calcium 1 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 254 | 1 | Calcium 3 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 371 | 1 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 16 | 1 | Phosphoserine; by autocatalysis Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 17 | 1 | Phosphothreonine; by autocatalysis Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 195 | 1 | Phosphotyrosine By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 314 | 1 | Phosphothreonine; by autocatalysis Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 324 | 1 | Phosphothreonine; by autocatalysis Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 500 | 1 | Phosphothreonine Ref.12 Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 504 | 1 | Phosphothreonine Ref.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 635 | 1 | Phosphothreonine; by autocatalysis | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 642 | 1 | Phosphothreonine Ref.15 Ref.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 661 | 1 | Phosphoserine; by autocatalysis Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 622 – 671 | 50 | RDKRD…FVINV → CGRNAENFDRFFTRHPPVLT PPDQEVIRNIDQSEFEGFSF VNSEFLKPEVKS in isoform Beta-II. | VSP_004738 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 144 | 1 | V → M in a colorectal adenocarcinoma sample; somatic mutation. Ref.16 | VAR_042304 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 496 | 1 | V → M in a glioblastoma multiforme sample; somatic mutation. Ref.16 | VAR_042305 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 588 | 1 | P → H Ref.16 | VAR_042306 | |||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 69 | 1 | V → G Ref.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 342 – 351 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 354 – 361 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 364 – 374 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 375 – 380 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 384 – 394 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 406 – 411 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 413 – 421 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 428 – 435 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 440 – 459 | 20 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 469 – 471 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 472 – 474 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 480 – 482 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 505 – 507 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 510 – 513 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 521 – 536 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 546 – 555 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 566 – 575 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 590 – 595 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 598 – 600 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 605 – 609 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 629 – 636 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 646 – 651 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 654 – 657 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways." Coussens L., Parker P.J., Rhee L., Yang-Feng T.L., Chen E., Waterfield M.D., Francke U., Ullrich A. Science 233:859-866(1986) [PubMed: 3755548] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-II). |
| [2] | "Primary structures of human protein kinase C beta I and beta II differ only in their C-terminal sequences." Kubo K., Ohno S., Suzuki K. FEBS Lett. 223:138-142(1987) [PubMed: 3666134] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS BETA-I AND BETA-II). |
| [3] | "Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q." Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R., Fuhrmann J., Mason T., Crosby M.L., Barnstead M., Cronin L., Mays A.D., Cao Y., Xu R.X., Kang H.-L., Mitchell S., Eichler E.E., Harris P.C., Venter J.C., Adams M.D. Genomics 60:295-308(1999) [PubMed: 10493829] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Hippocampus. |
| [5] | "Autoregulation of cloned human protein kinase C beta and gamma gene promoters in U937 cells." Mahajna J., King P., Parker P., Haley J. DNA Cell Biol. 14:213-222(1995) [PubMed: 7880442] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-69. |
| [6] | "Positive and negative regulation of the transcription of the human protein kinase C beta gene." Niino Y.S., Ohno S., Suzuki K. J. Biol. Chem. 267:6158-6163(1992) [PubMed: 1556124] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-58. |
| [7] | "Cloning and characterization of the major promoter of the human protein kinase C beta gene. Regulation by phorbol esters." Obeid L.M., Blobe G.C., Karolak L.A., Hannun Y.A. J. Biol. Chem. 267:20804-20810(1992) [PubMed: 1400396] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-57. |
| [8] | "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides." Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., Vandekerckhove J. Nat. Biotechnol. 21:566-569(2003) [PubMed: 12665801] [Abstract] Cited for: PROTEIN SEQUENCE OF 2-19, ACETYLATION AT ALA-2. Tissue: Platelet. |
| [9] | "The genomic structure of the human protein kinase C beta gene (PRKCB)." Greenham J.A., Adams M.D., Doggett N.A., Mole S.E. Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 97-176. |
| [10] | "Alternative splicing increases the diversity of the human protein kinase C family." Coussens L., Rhee L., Parker P.J., Ullrich A. DNA 6:389-394(1987) [PubMed: 3677994] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 609-671. Tissue: Fetal brain. |
| [11] | "Nucleotide sequence of the 3' portion of a human gene for protein kinase C beta-I/beta-II." Kubo K., Ohno S., Suzuki K. Nucleic Acids Res. 15:7179-7180(1987) [PubMed: 3658678] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 622-671. |
| [12] | "Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry." Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R., Keri G., Wehland J., Daub H. Mol. Cell. Proteomics 6:537-547(2007) [PubMed: 17192257] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-500 AND THR-504, MASS SPECTROMETRY. |
| [13] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-642, MASS SPECTROMETRY. Tissue: Platelet. |
| [14] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [15] | "Structure of the catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor." Grodsky N., Li Y., Bouzida D., Love R., Jensen J., Nodes B., Nonomiya J., Grant S. Biochemistry 45:13970-13981(2006) [PubMed: 17115692] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 321-660 IN COMPLEX WITH INHIBITOR, PHOSPHORYLATION AT THR-500; THR-642 AND SER-661. |
| [16] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed: 17344846] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] MET-144; MET-496 AND HIS-588. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M13975 mRNA. Translation: AAA60095.1. X06318 mRNA. Translation: CAA29634.1. X07109 mRNA. Translation: CAA30130.1. AC130454 Genomic DNA. No translation available. AC002299 Genomic DNA. Translation: AAB97933.1. AC002299 Genomic DNA. Translation: AAB97934.1. BC036472 mRNA. Translation: AAH36472.1. X62532 Genomic DNA. Translation: CAA44393.1. S47311 Genomic DNA. Translation: AAD13852.1. D10022 Genomic DNA. Translation: BAA00912.1. AJ002799, AJ002800 Genomic DNA. Translation: CAA05725.1. M18254 Genomic DNA. Translation: AAA60096.1. M18255 Genomic DNA. Translation: AAA60097.1. X05972 Genomic DNA. Translation: CAA29396.1. X05971 Genomic DNA. Translation: CAA29395.1. | |||||||||||||
| IPI | IPI00010466. IPI00219628. | ||||||||||||
| PIR | KIHUC2. B24664. KIHUC1. S00159. | ||||||||||||
| RefSeq | NP_002729.2. NP_997700.1. | ||||||||||||
| UniGene | Hs.460355 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| SMR | P05771. Positions 94-158, 95-159, 156-287, 157-288, 339-668. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | P05771. 5 interactions. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P05771. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | P05771. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSG00000166501. Homo sapiens. [Contig view] | ||||||||||||
| GeneID | 5579. | ||||||||||||
| KEGG | hsa:5579. | ||||||||||||
| UCSC | uc002dmc.1. human. uc002dmd.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| GeneCards | GC16P023755. | ||||||||||||
| H-InvDB | HIX0012899. | ||||||||||||
| HGNC | HGNC:9395. PRKCB. | ||||||||||||
| HPA | CAB003843. | ||||||||||||
| MIM | 176970. gene. | ||||||||||||
| PharmGKB | PA33761. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOVERGEN | P05771. | ||||||||||||
| OMA | P05771. SKFDNNG. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 2.7.11.13. 247. | ||||||||||||
| Pathway_Interaction_DB | cd8tcrdownstreampathway. Downstream signaling in naive CD8+ T cells. endothelinpathway. Endothelins. fcer1pathway. Fc-epsilon receptor I signaling in mast cells. il2_1pathway. IL2-mediated signaling events. tcrjnkpathway. JNK signaling in the CD4+ TCR pathway. tcrraspathway. Ras signaling in the CD4+ TCR pathway. nfat_3pathway. Role of Calcineurin-dependent NFAT signaling in lymphocytes. vegfr1_2_pathway. Signaling events mediated by VEGFR1 and VEGFR2. tcrpathway. TCR signaling in naive CD4+ T cells. cd8tcrpathway. TCR signaling in naive CD8+ T cells. txa2pathway. Thromboxane A2 receptor signaling. vegfr1_pathway. VEGFR1 specific signals. | ||||||||||||
| Reactome | REACT_604. Hemostasis. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P05771. | ||||||||||||
| Bgee | P05771. | ||||||||||||
| GermOnline | ENSG00000166501. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR000961. AGC-kinase_C. IPR000008. C2_Ca-dep. IPR018029. C2_membr_targeting. IPR002219. DAG_PE_bd. IPR015745. PKC. IPR017892. Pkinase_C. IPR000719. Prot_kinase_core. IPR017441. Protein_kinase_ATP_BS. IPR014375. Protein_kinase_C_a/b/g. IPR017442. Se/Thr_pkinase-rel. IPR008271. Ser_thr_pkin_AS. IPR002290. Ser_thr_pkinase. [Graphical view] | ||||||||||||
| PANTHER | PTHR22985:SF86. PKC. 1 hit. | ||||||||||||
| Pfam | PF00130. C1_1. 2 hits. PF00168. C2. 1 hit. PF00069. Pkinase. 1 hit. PF00433. Pkinase_C. 1 hit. [Graphical view] | ||||||||||||
| PIRSF | PIRSF000550. PKC_alpha. 1 hit. | ||||||||||||
| ProDom | PD000001. Prot_kinase. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||
| SMART | SM00109. C1. 2 hits. SM00239. C2. 1 hit. SM00133. S_TK_X. 1 hit. SM00220. S_TKc. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS51285. AGC_KINASE_CTER. 1 hit. PS50004. C2. 1 hit. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. PS00479. ZF_DAG_PE_1. 2 hits. PS50081. ZF_DAG_PE_2. 2 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| DrugBank | DB00163. Vitamin E. | ||||||||||||
| NextBio | 21632. | ||||||||||||
| PMAP-CutDB | P05771. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | KPCB_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P05771 Secondary accession number(s): O43744 Q9UJ33 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| SIMILARITY comments Index of protein domains and families |

Clusters with


